Trials / Completed
CompletedNCT03187938
Alkaline Phosphatase Level in Pregnancy and Its Association With Birth Weight
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 292 (actual)
- Sponsor
- TriHealth Inc. · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Alkaline phosphatase is known to be produced by syncytiotrophoblasts in the placenta and its levels are normally increased in pregnancy. Therefore, it would be reasonable to hypothesize that alkaline phosphatase would be low to low normal in cases of low birth weight / intrauterine growth restriction (IUGR)/ placental insufficiency.
Detailed description
The purpose of this study will be to determine if alkaline phosphatase can be used as a predictor for suboptimal fetal growth, placental insufficiency and low birth weight (birth weight less than 2500 grams). It will also help determine if alkaline phosphatase can be used as a screening tool for low birth weight/IUGR at the time of the 24 to 28 week labs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Testing of Alkaline Phosphatase Levels | Testing of alkaline phosphatase levels at the time of the 24w0d to 28w6d week labs. |
Timeline
- Start date
- 2017-06-14
- Primary completion
- 2019-08-05
- Completion
- 2019-08-05
- First posted
- 2017-06-15
- Last updated
- 2019-08-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03187938. Inclusion in this directory is not an endorsement.